Introduction
============

Diverticular hemorrhage accounts for approximately 20 % to 48 % of lower gastrointestinal bleeding (LGIB) and is the most commonly identifiable cause of LGIB [@JR1640-1] [@JR1640-2] [@JR1640-3] . Incidence of diverticular hemorrhage has been increasing with growing use of antithrombotic drugs in elderly patients [@JR1640-4] [@JR1640-5] [@JR1640-6] [@JR1640-7] .

Diverticular hemorrhage has a less severe course than upper gastrointestinal bleeding and stops spontaneously in 70 % to 80 % of cases [@JR1640-3] [@JR1640-8] . However, rebleeding occurs in approximately 25 % of these patients, with some requiring medical intervention [@JR1640-3] [@JR1640-8] [@JR1640-9] [@JR1640-10] . Moreover, the recurrent bleeding rate in patients with stigmata of recent hemorrhage (SRH) is reported to be relatively high (more than 60 %) with medication alone [@JR1640-11] .

After identification of SRH, the current standard treatment for diverticular bleeding is endoscopic hemostasis [@JR1640-11] [@JR1640-12] achieved by clipping, endoscopic band ligation (EBL), endoscopic detachable snare ligation therapy (EDSL), injection therapy, or thermal contact. EBL has been used more frequently than clipping because the early recurrent bleeding rate after EBL is lower than that with clipping [@JR1640-13] . However, adverse events (AEs) after EBL, such as diverticulitis and perforation, have been reported, albeit rarely [@JR1640-14] [@JR1640-15] .

The endoclip approach offers the theoretical advantage of causing less damage to adjacent tissues [@JR1640-16] [@JR1640-17] [@JR1640-18] . However, the efficacy of endoclips for diverticular bleeding remains unclear. In the current study, we retrospectively evaluated the safety and efficacy of endoclips versus EBL for treatment of colonic diverticular hemorrhage.

Patients and methods
====================

Study population
----------------

This was a retrospective study of patients who underwent colonoscopy with a diagnosis of LGIB between January 2013 and December 2018 at Nara City Hospital. Definite colonic diverticular hemorrhage was evident in 96 of 493 patients, with SRH being observed. SRH was defined as a densely adherent clot despite vigorous irrigation, a non-bleeding visible vessel, or active bleeding visualized on colonoscopy, SRH allowed for unequivocal identification of a specific diverticulum as the source of bleeding [@JR1640-19] [@JR1640-20] . In the first session, three of these patients were treated with transcatheter arterial embolization (TAE) instead of endoscopic therapy and 93 with endoscopic clipping or EBL. We classified the endoscopic clipping group into a direct clipping group and indirect clipping group. The current study was approved by the Institutional Review Board of Nara City Hospital and all patients provided informed consent before undergoing the procedure.

Colonoscopic examinations
-------------------------

All patients received standard supportive medical care for LGIB, including hemodynamic monitoring and fluid resuscitation. Packed red blood cells (RBCs) were transfused to correct severe anemia if necessary. Bowel preparation with polyethylene glycol or glycerin enema was performed before colonoscopic examinations. All patients underwent colonoscopy using water-jet scopes with a tip hood (PCF-Q260AZI or GIF-Q260 J: Olympus Optical Company Ltd., Tokyo, Japan), and a water-jet system was used for vigorous irrigation. To improve endoscopic visualization of colonic diverticula, we observed the colonic diverticulum under full water immersion [@JR1640-21] since 2016.

. Endoscopic hemostasis with endoclips (video)
----------------------------------------------

###### 

**Video 1** Direct clip placement.

We classified clipping methods into direct and indirect clipping. In the direct clipping method, endoclips (HX-610-090S EZ CLIP; Olympus Optical Company Ltd.) were placed directly onto the vessel ( [Fig. 1a](#FI1640-1){ref-type="fig"} , [Video 1](#ME1640-1){ref-type="media"} ). When direct placement of endoclips onto the vessel was not possible, the diverticulum was closed in a zipper manner ( [Fig. 1b](#FI1640-1){ref-type="fig"} ). In the indirect clipping method, endoscopists selected the type of endoclips (HX-610-090S, HX-610-135, or HX-610-090 L, EZ CLIP; Olympus Optical Company Ltd.) based on the shape of the diverticulum ( [Fig. 2](#FI1640-2){ref-type="fig"} ). In the current study, we distinguished between direct and indirect clip placement using endoscopic reports and colonoscopic images.

![ Endoscopic hemostasis with endoclips. **a1** Colonic diverticulum with a non-bleeding visible vessel. **a2** Endoclips were placed directly onto the vessel (direct clipping). **b1** Active bleeding from the colonic diverticulum. **b2** The diverticulum was closed in a zipper manner (indirect clipping).](10-1055-a-1036-6077-i1640ei1){#FI1640-1}

![ Types of endoclips. **a** HX-610-090S (short clip). **b** HX-610-135 (middle clip). **c** HX-610-090 L (long clip); EZ CLIP, Olympus Optical Company Ltd.](10-1055-a-1036-6077-i1640ei2){#FI1640-2}

Endoscopic hemostasis with EBL
------------------------------

At our institution, we introduced EBL for colonic diverticular hemorrhage in February 2016. The method of EBL used for colonic diverticular hemorrhage was the same as that reported previously [@JR1640-13] [@JR1640-22] [@JR1640-23] [@JR1640-24] . After the site of bleeding had been marked with endoclips, the colonoscope was removed and subsequently reinserted after attachment of a band-ligator device (MD-48912S EHL Devices; Sumitomo Bakelite Company Ltd., Tokyo, Japan). The diverticulum was pulled via suction into the cup of the endoscopic ligator, and the elastic O-ring was released.

Further treatment for rebleeding after initial endoscopic treatment
-------------------------------------------------------------------

Early rebleeding was defined as clinical evidence of recurrent LGIB within 30 days of initial treatment [@JR1640-19] . If rebleeding after initial endoscopic treatment occurred, a repeat endoscopic intervention was attempted. If diverticular rebleeding was not controlled by endoscopic retreatment, as in the case of massive rebleeding from previously treated diverticula, a poor endoscopic view, or hemodynamic instability, TAE or colectomy was performed based on the clinical judgment of the attending gastroenterologist.

Statistical analysis
--------------------

Ddemographics of patients, location of bleeding diverticula (cecum, ascending colon, transverse colon, descending colon, or sigmoid colon), bleeding point in the diverticulum (dome, neck, or unconfirmed), total procedural time, time to hemostasis after identification of the bleeding site, rate of early rebleeding, time to discharge after initial hemostasis, units of packed RBCs, and complications were retrospectively evaluated. Results obtained were expressed as medians (IQR, interquartile range) for continuous variables and proportions for categorical variables. A multilevel logistic regression analysis was performed to identify independent risk factors associated with early rebleeding, and odds ratios (ORs and 95 % confidence intervals (Cis) were calculated. The significance of differences was defined as *P*  \< 0.05. All statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), which is a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria). More precisely, it is a modified version of R commander designed to add statistical functions frequently used in biostatistics.

Results
=======

Patient characteristics
-----------------------

Patient characteristics in the direct clipping, indirect clipping, and EBL groups are shown in [Table 1](#TB1640-1){ref-type="table"} . Among 93 patients, 34, 28, and 31 were in the direct clipping group, indirect clipping group, and EBL group, respectively. In the indirect clipping group, an initial injection of hypertonic saline epinephrine solution (HSE) for diverticula with active bleeding was used for four patients. No significant differences were observed in age of patients, percentage of males, rate of hypertension, hyperlipidemia, chronic kidney disease, or heart disease, usage of nonsteroidal anti-inflammatory drugs (NSAIDs) and steroids, a previous history of colonic diverticular hemorrhage, hematocrit on admission, or the shock index between the three groups. The rate of diabetes mellitus was higher in the EBL group ( *P*  = 0.043 for the direct clipping group vs the EBL group, *P* values were calculated with Bonferroni corrections). The rate of cerebrovascular disease was not significantly different by Bonferroni corrections ( *P*  = 0.058 for the direct clipping group vs the EBL group). Furthermore, the rate of usage of antithrombotic agents was not significantly different by Bonferroni corrections ( *P*  = 0.099 for the indirect clipping group vs the EBL group). In the direct clipping group, nine patients were taking a single antithrombotic agent (aspirin 5, clopidogrel 2, edoxaban 1, and dipyridamole 1), while one received combination therapy (aspirin with clopidogrel). In the indirect clipping group, five patients were taking a single antithrombotic agent (aspirin 3, clopidogrel 1, and rivaroxaban 1), while two received combination therapy (aspirin with clopidogrel 1, and aspirin with warfarin 1). In the EBL group, 15 patients were taking a single antithrombotic agent (aspirin 4, clopidogrel 4, rivaroxaban 4, warfarin 2, and apixaban 1), while 2 received combination therapy (aspirin with cilostazol 1, and aspirin with clopidogrel 1).

###### Characteristics of patients who underwent endoscopic hemostasis for colonic diverticular hemorrhage with SRH

                                                               Direct clipping (n = 34)   Indirect clipping (n = 28)   EBL (n = 31)         *P* value
  ------------------------------------------------------------ -------------------------- ---------------------------- -------------------- -------------------------------------------
  Age, years, median (IQR)                                     75.5 (68--82.8)            76 (65.8--82)                72 (67--86.5)        0.757 [1](#FN1640-1){ref-type="table-fn"}
  Sex, male, n (%)                                             21 (61.8)                  15 (53.6)                    15 (48.4)            0.567 [2](#FN1640-2){ref-type="table-fn"}
  Comorbidity, n (%)                                                                                                                        
  Hypertension                                                 20 (58.8)                  14 (50.0)                    20 (64.5)            0.541 [2](#FN1640-2){ref-type="table-fn"}
  Hyperlipidemia                                                5 (14.7)                   1 (3.6)                      4 (12.9)            0.342 [2](#FN1640-2){ref-type="table-fn"}
  Diabetes mellitus                                             3 (8.8)                    3 (10.7)                    11 (39.3)            0.014 [2](#FN1640-2){ref-type="table-fn"}
  Chronic kidney disease                                        4 (11.8)                   2 (7.1)                      1 (3.2)             0.491 [2](#FN1640-2){ref-type="table-fn"}
  Heart disease                                                 3 (8.8)                    5 (17.9)                     8 (25.8)            0.19 [2](#FN1640-2){ref-type="table-fn"}
  Cerebrovascular disease                                       2 (5.9)                    4 (14.3)                     9 (29.0)            0.045 [2](#FN1640-2){ref-type="table-fn"}
  Usage of antithrombotic agents, n (%)                        10 (29.4)                   7 (25.0)                    17 (54.8)            0.039 [2](#FN1640-2){ref-type="table-fn"}
  Single agent                                                  9                          5                           15                   
  Combination use                                               1                          2                            2                   
  Usage of NSAIDs, n (%)                                        8 (23.5)                   8 (28.6)                    14 (45.2)            0.185 [2](#FN1640-2){ref-type="table-fn"}
  Usage of steroids, n (%)                                      1 (2.9)                    1 (3.6)                      0 (0)               0.754 [2](#FN1640-2){ref-type="table-fn"}
  Previous history of colonic diverticular hemorrhage, n (%)   19 (55.9)                  10 (35.7)                    18 (58.1)            0.178 [2](#FN1640-2){ref-type="table-fn"}
  Hb on admission, g/dL, median (IQR)                          11 (9.2--12.8)             11.8 (9.1--12.6)             12.1 (10.2--13.7)    0.1 [1](#FN1640-1){ref-type="table-fn"}
  Shock index on admission, median (IQR)                        0.64 (0.51--0.75)          0.63 (0.57--0.78)            0.64 (0.54--0.82)   0.952 [1](#FN1640-1){ref-type="table-fn"}

SRH, stigmata of recent hemorrhage; IQR, interquartile range; NSAIDs, nonsteroidal anti-inflammatory drugs; Hb, hemoglobin; EBL, endoscopic band ligation

One-way analysis of variance

Fisher's exact test

Clinical outcomes of patients who underwent endoscopic hemostasis for colonic diverticular hemorrhage with SRH
--------------------------------------------------------------------------------------------------------------

Clinical outcomes of direct clipping, indirect clipping, and EBL for treatment of colonic diverticular hemorrhage are shown in [Table 2](#TB1640-2){ref-type="table"} . A flowchart of treatment results is shown in [Fig. 3](#FI1640-3){ref-type="fig"} . Initial therapy successfully achieved immediate hemostasis without any procedural complications in all groups. After initial therapy, no complications occurred in any group. Location of hemorrhage, time to discharge after initial hemostasis, and units of packed RBCs were not significantly different between the three groups. The rate of active bleeding was significantly lower in the direct clipping group ( *P*  = 0.006 for the direct clipping group vs the indirect clipping group, *P* values were calculated with Bonferroni corrections). Total procedure time was longer in the EBL group ( *P*  = 0.019 for the direct clipping group vs the EBL group, *P* values were calculated with Bonferroni corrections). Time to hemostasis after identification of bleeding site was longer in the EBL group ( *P*  \< 0.001 for the direct clipping group vs the EBL group, *P* values were calculated with Bonferroni corrections). Rates of early rebleeding in the direct clipping, indirect clipping, and EBL groups were 5.9 % (2/34: 95 % CI, 0.7 %--19.7 %), 35.7 % (10/28: 95 % CI, 18.6 %--55.9 %), and 6.5 % (2/31: 95 % CI, 0.8 %--21.4 %), respectively ( *P*  = 0.006 for the direct clipping group vs the indirect clipping group, *P*  = 1 for the direct clipping group vs the EBL group, *P* values were calculated with Bonferroni corrections). Four patients in the indirect clipping group received an initial injection for diverticula with active bleeding, and one had early rebleeding.

###### Clinical outcomes of patients who underwent endoscopic hemostasis for colonic diverticular hemorrhage with SRH.

                                                                                    Direct clipping (n = 34)   Indirect clipping (n = 28)   EBL (n = 31)    *P* value
  --------------------------------------------------------------------------------- -------------------------- ---------------------------- --------------- -----------------------------------------------
  SRH (AB/ NBVV or AC), n                                                           13/21                      22/6                         21/10           0.004 [1](#FN1640-3){ref-type="table-fn"}
  Location (proximal: C, A, T/ distal: D, S), n                                     29/5                       19/9                         21/10           0.181 [1](#FN1640-3){ref-type="table-fn"}
  Bleeding point in the diverticulum (dome/neck/unconfirmed), n                     30/3/1                      6/0/22                      14/2/15         
  Total procedure time [2](#FN1640-4){ref-type="table-fn"} , min, median (IQR)      34 (26.3--52)              31.5 (20.8--55.3)            51 (38--72.5)   0.012 [3](#FN1640-5){ref-type="table-fn"}
  Time to hemostasis after identification of the bleeding site, min, median (IQR)    9 (5.5--13)                6 (3.8--11.3)               24 (14--31.5)    \< 0.001 [3](#FN1640-5){ref-type="table-fn"}
  Early rebleeding [4](#FN1640-6){ref-type="table-fn"} , n (%)                       2 (5.9)                   10 (35.7)                     2 (6.5)        0.003 [1](#FN1640-3){ref-type="table-fn"}
  Time to discharge after initial hemostasis, day, median (IQR)                      7 (5--8)                   6.5 (6--9)                   5 (4--7)       0.1 [5](#FN1640-7){ref-type="table-fn"}
  Units of PRBCs, median (IQR)                                                       0 (0--2)                   0 (0--4)                     0 (0--0)       0.195 [5](#FN1640-7){ref-type="table-fn"}
  Complications, n                                                                   0                          0                            0              1 [1](#FN1640-3){ref-type="table-fn"}

SRH, stigmata of recent hemorrhage; AB, active bleeding; NBVV, non-bleeding visible vessel; AC, adherent clot; C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon; IQR, interquartile range; PRBCs, packed red blood cells; EBL, endoscopic band ligation.

Fisher's exact test

The total procedure time is defined as the total time from the start to end of colonoscopy

One-way analysis of variance

Early rebleeding is defined as rebleeding within 30 days of initial hemostasis

Welch's test

![ Flowchart of treatment results. SRH, stigmata of recent hemorrhage; EBL, endoscopic band ligation; TAE, transcatheter arterial embolization; Early rebleeding, recurrent bleeding within 30 days of treatment. \* *P*  = 0.006 for the direct clipping group vs the indirect clipping group; \*\* *P*  = 1 for the direct clipping group vs the EBL group.  *P* values were calculated with Bonferroni corrections.](10-1055-a-1036-6077-i1640ei3){#FI1640-3}

Annual changes in endoscopic hemostasis and rebleeding cases
------------------------------------------------------------

Annual changes in endoscopic hemostasis and rebleeding cases are shown in [Table 3](#TB1640-3){ref-type="table"} . Direct clipping slightly increased from 2015, while indirect clipping slightly decreased from 2016. Our institution introduced EBL in 2016. EBL has been increasing every year.

###### Annual changes in endoscopic hemostasis and rebleeding.

  Endoscopic hemostasis                                                                    
  ----------------------------------------------------- ------ ------ ------ ------ ------ ------
  Year                                                  2013   2014   2015   2016   2017   2018
  Direct clipping, n                                    0      3      5      11      5     10
  Indirect clipping, n                                  5      9      7       4      2      1
  EBL, n                                                0      0      0       5     10     16
  Rebleeding cases according to endoscopic hemostasis                                      
  Year                                                  2013   2014   2015   2016   2017   2018
  Direct clipping, n                                    0      0      0       0      1      1
  Indirect clipping, n                                  2      2      3       2      0      1
  EBL, n                                                0      0      0       0      2      0

EBL, endoscopic band ligation.

Characteristics of early rebleeding cases after hemostasis
----------------------------------------------------------

Characteristics of early rebleeding cases after hemostasis are shown in [Table 4](#TB1640-4){ref-type="table"} .

###### Characteristics of recurrent bleeding and non-recurrent bleeding groups after endoscopic hemostasis.

                                                                                    Non-recurrent bleeding (n = 79)   Recurrent bleeding (n = 14)   *P* value
  --------------------------------------------------------------------------------- --------------------------------- ----------------------------- -----------
  Age, years, median (IQR)                                                          75 (66.5--82.5)                   78 (69.3--85.3)               0.572
  Sex, male, n (%)                                                                  45 (57.0)                          6 (42.9)                     0.39
  Comorbidity, n (%)                                                                                                                                
  Hypertension                                                                      48 (60.8)                          6 (42.9)                     0.248
  Hyperlipidemia                                                                     9 (11.4)                          1 (7.1)                      1
  Diabetes mellitus                                                                 17 (21.5)                          0 (0)                        0.065
  Chronic kidney disease                                                             7 (8.9)                           0 (0)                        0.589
  Heart disease                                                                     15 (19.0)                          1 (7.1)                      0.45
  Cerebrovascular disease                                                           12 (15.2)                          3 (21.4)                     0.693
  Usage of antithrombotic agents, n (%)                                             28 (35.4)                          6 (42.9)                     0.764
  Usage of NSAIDs, n (%)                                                            25 (31.6)                          5 (35.7)                     0.764
  Usage of steroids, n (%)                                                           2 (2.5)                           0 (0)                        1
  Previous history of colonic diverticular hemorrhage, n (%)                        40 (50.6)                          7 (50.0)                     1
  Endoscopic hemostasis, n (%)                                                      0.003                                                           
  Direct clipping                                                                   32 (40.5)                          2 (14.3)                     
  Indirect clipping                                                                 18 (22.8)                         10 (71.4)                     
  EBL                                                                               29 (36.7)                          2 (14.3)                     
  SRH (AB/ NBVV or AC), n                                                           44/35                             12/2                          0.041
  Location (proximal: C, A, T/ distal: D, S), n                                     60/19                              9/5                          0.343
  Bleeding point in the diverticulum (dome/neck/unconfirmed), n                     44/5/30                            6/0/9                        0.417
  Total procedure time [1](#FN1640-8){ref-type="table-fn"} , min, median (IQR)      40 (29--57)                       28 (17.3--63)                 0.429
  Time to hemostasis after identification of the bleeding site, min, median (IQR)   12 (7--19)                         9.5 (3.5--13)                0.247

IQR, interquartile range; NSAIDs, nonsteroidal anti-inflammatory drugs; EBL, endoscopic band ligation; SRH, stigmata of recent hemorrhage; AB, active bleeding; NBVV, non-bleeding visible vessel; AC, adherent clot; C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon.

The total procedure time is defined as the total time from the start to end of colonoscopy

Two patients (5.9 %) in the direct clipping group had early rebleeding and underwent EBL ( [Fig. 3](#FI1640-3){ref-type="fig"} ). No further bleeding occurred after repeat therapy, and neither surgical nor angiographic therapy was required. Ten patients (35.7 %) in the indirect clipping group had early rebleeding. Although seven patients were managed conservatively or endoscopically, TAE or colectomy was performed on three patients because of uncontrollable hemorrhage ( [Fig. 3](#FI1640-3){ref-type="fig"} ). Two patients (6.5 %) in the EBL group had early rebleeding. TAE was performed on one patient. In the EBL group, no further bleeding occurred after repeat therapy ( [Fig. 3](#FI1640-3){ref-type="fig"} ).

Risk factors associated with early rebleeding after endoscopic hemostasis
-------------------------------------------------------------------------

Multilevel logistic regression analysis was performed to verify the influence of endoscopic hemostasis on early rebleeding ( [Table 5](#TB1640-5){ref-type="table"} ). We adjusted for age, sex, use of antithrombotic agents and NSAIDs, and SRH (active bleeding). Only indirect clipping was identified as an independent risk factor for early rebleeding after endoscopic hemostasis (OR, 12.7; 95 % CI 2.02--79.4; P = 0.0067).

###### Multilevel logistic regression analysis to identify independent risk factors associated with early rebleeding.

                                   Odds ratio   95 % CI       *P* value
  -------------------------------- ------------ ------------- -----------
  Age                              0.998        0.93--1.07    0.948
  Sex (Male)                       0.457        0.11--1.96    0.291
  Usage of antithrombotic agents   2.67         0.587--12.2   0.204
  Usage of NSAIDs                  1.22         0.287--5.18   0.789
  SRH (active bleeding)            3.83         0.644--22.8   0.14
  Endoscopic hemostasis                                       
  EBL                              1                          
  Direct clipping                  1.91         0.216--16.8   0.561
  Indirect clipping                12.7         2.02--79.4    0.0067

NSAIDs, nonsteroidal anti-inflammatory drugs; SRH, stigmata of recent hemorrhage; EBL, endoscopic band ligation; CI, confidence interval.

. Discussion
============

###### 

**Video 2**  Devices for direct clip placement.

The current study showed two important clinical issues: the early rebleeding rate was as low in the direct clipping group as that in the EBL group, but was higher in the indirect clipping group than in the other groups.

In the current study, the early rebleeding rate with direct placement was 5.9 %. This is lower than the rates reported in a previous systematic review and meta-analysis [@JR1640-25] , with rates of 19 % for clipping and 21 % for thermal contact, which were similar to that for EBL (9 %). The early rebleeding rates of patients treated with endoclips were previously reported to be between 0 % and 50 %, which is a wide range [@JR1640-13] . We speculate that these differences in early rebleeding rates following endoclips depend on whether endoclips are placed directly on vessels. Hemostasis with direct clip placement is sometimes considered to be difficult [@JR1640-22] . The following factors complicate direct clip placement: 1) endoscopic observations in colonic diverticula; 2) insertion of endoclips into colonic diverticula; and 3) stability of the endoscope. We attempted to overcome these issues using the following strategies. To improve endoscopic visualization of colonic diverticula and endoscope stability, we observed a colonic diverticulum under full water immersion using a water-jet scope with a tip hood [@JR1640-21] . Water immersion observations are advantageous because water immersion significantly improves endoscopic visualization and water pressure dilates a colonic diverticulum without insufflation. To facilitate insertion of endoclips into the diverticulum, we placed an open endoclip into the forceps hole of the endoscope, which reduced the width of the endoclip ( [Fig. 4](#FI1640-4){ref-type="fig"} ). This step facilitated insertion of the endoclip into the colonic diverticulum. We also used a longer tip hood (approximately 7 mm), which enables rotation of an endoclip in the tip hood and more accurate placement. These devices make it easier to place endoclips directly ( [Video 2](#ME1640-2){ref-type="media"} ). We introduced these devices in 2016. The proportion of direct clip placement increased to 40.6 % (26/64: between 2016 and 2018) from 24.1 % (7/29: between 2013 and 2015) ( [Table 3](#TB1640-3){ref-type="table"} ).

![An open endoclip (HX-610-090S; EZ CLIP, Olympus Optical Company Ltd.). **b** After the open endoclip is placed into the forceps hole of the endoscope, the width of the endoclip becomes narrower.](10-1055-a-1036-6077-i1640ei4){#FI1640-4}

In the current study, two patients in the direct clipping group had early rebleeding. In one of these patients, direct clip placement was performed for massive active bleeding ( [Fig. 5a](#FI1640-5){ref-type="fig"} ). Although bleeding was stopped by clipping ( [Fig. 5b](#FI1640-5){ref-type="fig"} ), rebleeding occurred 16 hours later. Colonoscopy was performed, and an exposed vessel with a clot was observed beside the endoclips ( [Fig. 5c](#FI1640-5){ref-type="fig"} ). The diverticulum with endoclips was pulled via suction into the cup of the endoscopic ligator, and the elastic O-ring was released ( [Fig. 5d](#FI1640-5){ref-type="fig"} ). This case suggested that the endoclips did not capture the bleeding source, and also that direct clip placement is not recommended for massive active bleeding because of the poor visual field.

![Active bleeding from the colonic diverticulum. **b** Bleeding was stopped after direct clip placement. **c** An exposed vessel with a clot beside the endoclips (yellow arrow). **d** The diverticulum was pulled via suction into the cup of the endoscopic ligator, and the elastic O-ring was released. The yellow arrow indicates the diverticulum with endoclips after EBL.](10-1055-a-1036-6077-i1640ei5){#FI1640-5}

In the current study, the rate of active bleeding was significantly lower in the direct clipping group, which may have contributed to the low rate of early rebleeding in the direct clipping. However, the multilevel logistic regression analysis to identify independent risk factors associated with early rebleeding showed that active bleeding was not a risk factor for early bleeding ( [Table 5](#TB1640-5){ref-type="table"} : *P*  = 0.14).

On the other hand, the early rebleeding rate in the indirect clipping group was high (35.7 %: 10/28). The reason for this was that the bleeding source was not captured by indirect clip placement. Ishi et al. reported that the early rebleeding rate of patients treated with endoclips was 34 % (30 out of 87 cases); indirect placement in a zipper manner was performed on 85 % of patients. Indirect clip placement does not always achieve complete hemostasis because of the arcades of arteries from the neck that join and form the artery in the base of the diverticulum [@JR1640-13] [@JR1640-24] [@JR1640-33] . These findings suggest that indirect placement of hemoclips for bleeding diverticula is ineffective for hemostasis. Moreover, Kume et al. reported a case of sepsis caused by indirect placement of endoclips for colon diverticular bleeding [@JR1640-34] ; a diverticulum with continuous arterial spurting was closed with endoclips in a zipper manner, and the patient developed sepsis on the next day. This case report suggests that a seamed diverticulum with active bleeding permits bacteria to invade blood vessels. Therefore, indirect clip placement is not recommended from the viewpoint of effectiveness and complications.

Incidence of diverticular hemorrhage has been increasing with growing use of antithrombotic drugs in elderly patients [@JR1640-4] [@JR1640-5] [@JR1640-6] [@JR1640-7] . In the current study, 37.6 % (35/93) of subjects were older than 80 years. If complications occur in these patients, they may become severe. AEs such as colonic diverticulitis and perforation after EBL have been reported, albeit rarely [@JR1640-14] [@JR1640-15] . Akutsu et al. evaluated efficacy and safety of EDSL in patients with colonic diverticular bleeding without severe comorbidities. In that study [@JR1640-35] , one of 101 patients treated with EDSL developed diverticulitis. These findings suggest that the safety of ligation methods, such as EBL and EDSL, for patients with severe comorbidities remains unclear. Therefore, treatment of these patients needs to be minimally invasive.

The endoclip approach offers the theoretical advantage of causing less damage to adjacent tissues [@JR1640-17] [@JR1640-18] [@JR1640-36] . Moreover, endoclips are cheaper than EBL and EDSL. When rebleeding occurs after direct clip placement, the bleeding point can be treated with EBL ( [Fig. 5](#FI1640-5){ref-type="fig"} ). Therefore, direct clip placement is acceptable as the first choice for colonic diverticulum hemorrhage. At our institution, direct clip placement has been the first choice for colonic diverticulum bleeding in recent years. The overall rebleeding rate in our institution was lower between 2016 and 2018 (10.9 %: 7/64) than between 2013 and 2015 (24.1 %: 7/29) ( [Table 3](#TB1640-3){ref-type="table"} ). These results indicate that the correct strategy to achieve hemostasis was selected. A safe and cost-effective treatment may be selected by evaluating the form of the diverticulum, maneuverability of the colonoscope, and condition of the bleeding site.

The current study has several limitations. One of the main limitations that need to be addressed is that we treated bleeding without standardization. Furthermore, this was a non-randomized retrospective study that involved some selection bias. We distinguished between direct and indirect clip placement using endoscopic reports and images from colonoscopy. Selection bias for judgements is also a major issue. Decision-making and procedure skills must have differed to some extent among endoscopists. In the future, we intend to conduct a retrospective multicenter study with a larger number of patients.

Conclusion
==========

In summary, direct clip placement is acceptable as the first treatment choice for colonic diverticular hemorrhage. When direct placement of endoclips is not possible, a ligation method such as EBL and EDSL needs to be performed instead of indirect clipping.
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